More than 100 days into President Donald Trump’s second term, the administration has fallen into a pattern. Trump releases an executive order with an expansive title accompanied by even more expansive claims from the president and senior officials about the effects of the directive.

The president has long complained that the United States pays more for medicines than other wealthy countries. But he offered no clear legal authority to mandate lower prices.

Countries with universal healthcare systems have stronger bargaining power, which has allowed them to effectively negotiate lower drug prices.